Biotechnological applications of Listeria's sophisticated infection strategies.
Listeria monocytogenes is a Gram-positive bacterium that is able to survive both in the environment and to invade and multiply within eukaryotic cells. Currently L. monocytogenes represents one of the most well-studied and characterized microorganisms in bacterial pathogenesis. A hallmark of L. monocytogenes virulence is its ability to breach bodily barriers such as the intestinal epithelium, the blood-brain barrier as well as the placental barrier to cause severe systemic disease. Curiously, this theme is repeated at the level of the interaction between the individual cell and the bacterium where its virulence factors contribute to the ability of the bacteria to breach cellular barriers. L. monocytogenes is a model to study metabolic requirements of bacteria growing in an intracellular environment, modulation of signalling pathways in the infected cell and interactions with cellular defences involving innate and adaptive immunity. Technical advances such as the creation of LISTERIA-susceptible mouse strains, had added interest in the study of the natural pathogenesis of the disease via oral infection. The use of attenuated strains of L. monocytogenes as vaccines has gained considerable interest because they can be used to express heterologous antigens as well as to somatically deliver recombinant DNA to eukaryotic cells. A novel vaccine concept, the use of non-viable but metabolically active bacteria to induced immunoprotective responses, has been developed with L. monocytogenes. In this mini-review, we review the strategies used by L. monocytogenes to subvert the cellular functions at different stages of the infection cycle in the host and examine how these properties are being exploited in biotechnological and clinical applications.
Institute for Medical Microbiology, Justus-Liebig University, Frankfurter strasse 107, D-35392 Giessen, Germany.
Sukhadeo
S
Barbuddhe
Trinad
T
Chakraborty
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D001709:Biotechnology; D004195:Disease Models, Animal; D006801:Humans; D008087:Listeria / Q000235:genetics / Q000472:pathogenicity / Q000502:physiology*; D008088:Listeriosis / Q000378:metabolism / Q000382:microbiology*; D051379:Mice; D011485:Protein Binding; D014774:Virulence
D001426:Bacterial Proteins
Cell Physiol Biochem. 2007;20(6):1051-60
17975307
EMBO J. 2005 Aug 3;24(15):2827-38
16015374
Infect Immun. 1998 Aug;66(8):3758-66
9673259
J Clin Invest. 2005 Sep;115(9):2472-9
16110326
Nat Med. 2006 May;12(5):515-7
16633349
Infect Immun. 2007 Jan;75(1):44-51
17060464
Infect Immun. 1997 Dec;65(12):5309-19
9393831
Science. 2001 Jun 1;292(5522):1722-5
11387478
Infect Immun. 2005 Jul;73(7):4410-3
15972539
Infect Immun. 2003 Dec;71(12):6754-65
14638761
Mol Cell Biol. 2007 Oct;27(19):6615-28
17682062
Mol Microbiol. 1999 Oct;34(1):10-23
10540282
Science. 1996 Nov 1;274(5288):780-2
8864117
Infect Immun. 2005 Apr;73(4):2061-74
15784547
Cell. 1991 Jun 28;65(7):1127-41
1905979
Cell. 2007 Jun 1;129(5):891-902
17540170
Annu Rev Microbiol. 2004;58:587-610
15487949
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5192-7
15795386
Adv Drug Deliv Rev. 2000 Mar 30;41(2):209-21
10699316
J Bacteriol. 1997 Mar;179(5):1533-40
9045810
Cell Microbiol. 2007 Jan;9(1):179-95
17222191
Nat Cell Biol. 2005 Oct;7(10):954-60
16184169
Science. 2004 Feb 6;303(5659):851-3
14764883
Cell Microbiol. 2006 Feb;8(2):353-64
16441444
Infect Immun. 2006 Feb;74(2):1323-38
16428782
Science. 2003 Oct 17;302(5644):462-4
14564012
Cell. 2003 Feb 21;112(4):535-48
12600316
Sci Prog. 2007;90(Pt 1):1-14
17455762
Nat Med. 2005 Aug;11(8):853-60
16041382
J Cell Biol. 1989 Oct;109(4 Pt 1):1597-608
2507553
Cell Microbiol. 2002 Aug;4(8):483-91
12174083
Cell Microbiol. 2005 Sep;7(9):1345-56
16098221
Clin Microbiol Rev. 2001 Jul;14(3):584-640
11432815
J Cell Biol. 2002 Aug 5;158(3):409-14
12163465
Infect Immun. 2002 Mar;70(3):1334-41
11854218
J Gene Med. 2005 Aug;7(8):1077-85
15776501
EMBO J. 1998 Jul 15;17(14):3797-806
9669997
Mol Microbiol. 1993 Apr;8(1):143-57
8388529
Am J Physiol Cell Physiol. 2003 Dec;285(6):C1553-60
14600080
PLoS Pathog. 2006 Jun;2(6):e66
16846254
J Gene Med. 2002 Nov-Dec;4(6):655-67
12439857
Cell Microbiol. 2005 Jul;7(7):1035-48
15953034
J Immunol. 2006 Sep 15;177(6):4012-20
16951364
Traffic. 2005 Jun;6(6):459-73
15882443
Cell Microbiol. 2006 May;8(5):781-92
16611227
Mol Microbiol. 1995 Apr;16(2):251-61
7565087
J Pathol. 2006 Jan;208(2):215-23
16362984
Trends Microbiol. 2002 May;10(5):238-45
11973158
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):431-6
11756655
Infect Immun. 1987 Nov;55(11):2822-9
3117693
Infect Immun. 2000 Oct;68(10):5735-41
10992479
Autophagy. 2007 Mar-Apr;3(2):117-25
17204850
J Infect Dis. 2004 Feb 1;189(3):393-401
14745696
Infect Immun. 1998 Aug;66(8):3673-81
9673248
Nature. 2008 Jan 17;451(7176):350-4
18202661
Infect Immun. 1996 Jun;64(6):2359-61
8675352
Nat Rev Microbiol. 2006 Jun;4(6):423-34
16710323
Immunobiology. 1999 Dec;201(2):155-63
10631564
Cell Microbiol. 2003 Dec;5(12):901-11
14641175
Trends Cell Biol. 2004 Jun;14(6):303-11
15183187
Mol Microbiol. 1998 Jun;28(6):1081-9
9680200
J Cell Biol. 1997 Apr 7;137(1):155-67
9105044
Mol Microbiol. 2005 Feb;55(4):1183-95
15686563
J Immunol. 1997 Aug 15;159(4):1970-6
9257863
Infect Immun. 1998 Feb;66(2):747-55
9453636
Infect Immun. 1995 Nov;63(11):4231-7
7591052
Mol Microbiol. 1997 Jul;25(2):285-94
9282740
J Cell Sci. 2005 Apr 1;118(Pt 7):1537-47
15769844
Curr Opin Biotechnol. 2001 Oct;12(5):467-72
11604322
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13646-51
16157870
Mol Microbiol. 2004 Mar;51(6):1601-14
15009888
Infect Immun. 2002 Aug;70(8):4650-60
12117979
J Cell Biol. 2004 Aug 30;166(5):743-53
15337781
Cell Microbiol. 2005 Mar;7(3):443-57
15679846
Curr Opin Mol Ther. 2003 Feb;5(1):10-9
12669465
EMBO J. 1992 May;11(5):1981-90
1582425
Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12221-6
11572936
J Gene Med. 2005 Aug;7(8):1097-112
16001391
EMBO J. 1999 Jul 15;18(14):3956-63
10406800
Cell. 2000 Oct 27;103(3):501-10
11081636
Int J Food Microbiol. 2000 Sep 25;60(2-3):137-46
11016603
Cell Death Differ. 2003 Feb;10(2):249-56
12700653
Cell Microbiol. 2000 Dec;2(6):487-504
11207603
Expert Rev Vaccines. 2006 Aug;5(4):541-52
16989634
J Cell Biol. 2001 Oct 1;155(1):101-12
11571311
J Infect Dis. 2004 Jun 1;189(11):2094-100
15143478
Infect Immun. 1993 Apr;61(4):1576-80
8384163
Curr Opin Cell Biol. 2005 Oct;17(5):489-98
16102958
Mol Microbiol. 1996 Apr;20(1):119-26
8861210
Infect Immun. 2005 Feb;73(2):894-904
15664931
J Cell Biol. 1997 Jun 16;137(6):1381-92
9182669
Front Biosci. 2004 May 01;9:1294-310
14977545
Cell Microbiol. 2002 Mar;4(3):177-86
11906454
Nat Rev Immunol. 2004 Oct;4(10):812-23
15459672
Cell. 1992 Feb 7;68(3):521-31
1739966
Mol Microbiol. 2004 Jul;53(2):639-49
15228540
Appl Environ Microbiol. 2008 Mar;74(6):1892-901
18223114
J Biotechnol. 2006 Oct 20;126(1):37-51
16757050
Science. 2005 Aug 19;309(5738):1248-51
16020693
Cell Microbiol. 2006 Jan;8(1):107-19
16367870
Cell Microbiol. 2001 Dec;3(12):853-64
11736996
Clin Infect Dis. 2000 Sep;31(3):770-5
11017828
EMBO J. 2005 Mar 23;24(6):1287-300
15729356
PLoS Pathog. 2006 Jan;2(1):e3
16446782
Nat Cell Biol. 2005 Sep;7(9):894-900
16113677
Clin Microbiol Infect. 2005 Jun;11(6):430-6
15882192